BSG and pulmonary fibrosis: In conclusion, our study provides an ideal model for studying the fibrotic pathogenesis of COVID-19, discovers a novel function of CD147 contributing to the activation of lung fibroblasts, and provides a promising drug against COVID-19 pulmonary fibrosis.